Immune response during interferon beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse-free in the START study. Dhib-Jalbut S, Sumandeep S, Valenzuela R, Ito K, Patel P, Rametta M J Neuroimmunol. 2012 Sep 18. PMID: 22999187. Abstract CommentRecommendBookmarkWatch